| Name | Niox Group |
|---|---|
| Epic | NIOX |
| Isin | GB00BJVD3B28 |
| Index | AIM50 AIM350 |
| Industry | Medical Equipment and Services |
| Latest share price | 64.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £271.44 | Debt ratio | n/a |
| Shares in issue | 422.05 | Debt-to-equity ratio | n/a |
| P/E ratio | 17.3 | Assets / equity ratio | n/a |
| Total dividends per share | 3.50p | Price to book value | n/a |
| Dividend yield | 5.2 | ROCE | 6.72 |
| Dividend cover | 1.11 | EPS growth | 42 |
| Earning per share | 2.26 | 52-week high / low | 58.00p / 75.20p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2024-05-23 | 2024-06-24 | 1.00p |
| Special | 2023-08-17 | 2023-09-15 | 2.50p |
| Company name | Niox Group |
|---|---|
| Address | Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom, OX4 4GB |
| Telephone | +44 (0)1865 405560 |
| Website | http://www.niox.com/ |
| Director | Position |
|---|---|
| Mr Nicholas Mills | Non-Executive Director |
| Mr Ian Johnson | Executive Chairman |
| Mr Garry Watts | Senior Independent Director |
| Mr Michael R D Roller | Chief Finance Officer |
| Mr Jo Le Couilliard | Independent Non-Executive Director |
| Mr Sharon Curran | Independent Non-Executive Director |
| Mr Jonathan Emms | Chief Operating Officer |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 32.8 | 37.1 | 42.1 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 58 | 67.1 | 66.6 |
| Inventory / work in progress | 4.8 | 4.1 | 2.7 |
| Trade and other receivables | 8.8 | 7.9 | 4.5 |
| Cash and equivalents | 19.9 | 19.4 | 12.6 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 91.5 | 98.5 | 86.4 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 7.2 | 9.2 | 10.8 |
| Long term liabilities | 0.5 | 7.4 | 8.8 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 7.7 | 16.6 | 19.6 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 83.8 | 81.9 | 66.8 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.3 | 0.3 | 0.3 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 65.2 | -574.4 | -590.5 |
| Share premium account | 0.1 | 640.3 | 640.3 |
| Total equity | 83.8 | 81.9 | 66.8 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 4.6 | 1.8 | -4.3 |
| Pre-tax profit | 4.1 | 10.5 | -2.1 |